Peptide Analogs — Series B
Cagrilintide Research Peptide
Cagrilintide is a long-acting acylated analog of human amylin studied for amylin and calcitonin receptor signaling. Supplied lyophilized as a laboratory reference compound. For research use only.
$59.99 — 10mg vial
| Purity | ≥99% |
| Quantity | 10mg |
| Molecular Weight | 3963.5 g/mol |
| Sequence | Long-acting amylin analog (33-amino-acid, acylated) |
| Category | Peptide Analogs — Series B |
Research Overview
- Investigated for amylin receptor (AMY1-3) and calcitonin receptor engagement
- Studied for satiety signaling pathways in preclinical models
- Research into gastric emptying rate modulation in animal studies
- Explored for extended half-life relative to native amylin via acylation
- Preclinical profiling of combined amylin and incretin pathway research
Quality & Testing
Every Cagrilintide batch is verified by independent third-party HPLC and mass-spectrometry testing, with a batch-specific certificate of analysis available on the COA page.
Laboratory Handling & Storage
Lyophilized peptides are supplied as a freeze-dried powder and are most stable stored cold (2–8°C), protected from light and moisture, in the original sealed vial. Under these conditions the research literature generally reports multi-year integrity for dry peptide material.
Once reconstituted in a laboratory setting, solutions are typically stored refrigerated and used within the window appropriate to the diluent and compound; repeated freeze–thaw cycles are avoided because they can promote aggregation. See our research overview on reconstitution and lyophilization for the underlying formulation science.